$14.99
-0.3-1.96%
At Close: -
$14.99
00.00%
After Hours: Sep 20, 4:40 PM EDT
15 minutes delayed
Immunome reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Immunome using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $-0.60 | $-0.39 | -53.8 % |
Mar 2024 | 2024-05-14 | $-0.34 | $-0.69 | 50.7 % |
Dec 2023 | 2024-03-28 | $-0.15 | $-0.28 | 46.4 % |
Jun 2023 | 2023-08-09 | $-0.46 | $-0.16 | -187.5 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-12 | $2.36M | $2.55M | -7.29 % |
Mar 2024 | 2024-05-14 | $1.03M | $2.50M | -58.8 % |
Dec 2023 | 2024-03-28 | $3.83M | $2.07M | 84.8 % |
Jun 2021 | 2021-08-16 | $0 | $3.80M | -100.0 % |
Immunome (IMNM) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 12, 2024 for Q2.
The Actual EPS was $-0.60, which missed the estimate of $-0.39.
The Actual Revenue was $2.4M, which missed the estimate of $2.5M.
Browse earnings estimates, EPS, and revenue on all stocks.